{"id":65060,"date":"2026-05-12T15:08:32","date_gmt":"2026-05-12T07:08:32","guid":{"rendered":"https:\/\/flcube.com\/?p=65060"},"modified":"2026-05-12T15:08:33","modified_gmt":"2026-05-12T07:08:33","slug":"nmpa-releases-105th-batch-of-generic-drug-reference-standards-adding-37-new-specifications","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=65060","title":{"rendered":"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications"},"content":{"rendered":"\n<p>China&#8217;s <strong>National Medical Products Administration (NMPA)<\/strong> announced the release of the <strong>105th batch of reference drugs<\/strong> for <strong>Generic Quality Consistency Evaluation (GQCE)<\/strong> work, comprising <strong>59 specifications<\/strong> in total. The batch includes <strong>37 newly added specifications<\/strong>, with the remaining <strong>22 specifications<\/strong> undergoing modifications to existing reference standards.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-update-details\">Regulatory Update Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Regulatory Body<\/strong><\/td><td>National Medical Products Administration (NMPA)<\/td><\/tr><tr><td><strong>Batch Number<\/strong><\/td><td>105th batch of GQCE reference drugs<\/td><\/tr><tr><td><strong>Total Specifications<\/strong><\/td><td>59<\/td><\/tr><tr><td><strong>New Additions<\/strong><\/td><td>37 specifications<\/td><\/tr><tr><td><strong>Modifications<\/strong><\/td><td>22 existing specifications<\/td><\/tr><tr><td><strong>Program<\/strong><\/td><td>Generic Quality Consistency Evaluation (GQCE)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-program-context-amp-significance\">Program Context &amp; Significance<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>GQCE Initiative:<\/strong> China&#8217;s comprehensive program to ensure generic drugs demonstrate bioequivalence to reference listed drugs (RLDs)<\/li>\n\n\n\n<li><strong>Market Impact:<\/strong> Reference drug designation enables generic manufacturers to conduct required comparative studies for market approval<\/li>\n\n\n\n<li><strong>Quality Standards:<\/strong> Part of China&#8217;s ongoing efforts to elevate generic drug quality to international standards<\/li>\n\n\n\n<li><strong>Healthcare Cost Control:<\/strong> Supports national strategy to reduce pharmaceutical expenditures through high-quality, lower-cost generics<\/li>\n\n\n\n<li><strong>Industry Implications:<\/strong> Creates clear development pathways for domestic generic manufacturers while increasing competition<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-significance\">Strategic Significance<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Aspect<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Market Access Clarity<\/strong><\/td><td>Provides definitive reference standards for generic developers, reducing regulatory uncertainty<\/td><\/tr><tr><td><strong>Competitive Landscape<\/strong><\/td><td>Opens opportunities for first-to-file generic entrants in newly referenced specifications<\/td><\/tr><tr><td><strong>Healthcare System Benefits<\/strong><\/td><td>Accelerates availability of cost-effective therapeutic alternatives for Chinese patients<\/td><\/tr><tr><td><strong>International Alignment<\/strong><\/td><td>Continues China&#8217;s convergence with global regulatory standards for generic drug approval<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The 105th batch continues the NMPA&#8217;s systematic approach to expanding the reference drug catalog, which has now covered thousands of specifications since the GQCE program&#8217;s inception.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-outlook\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Generic Development Pipeline<\/strong> | Immediate activation of development programs by Chinese pharmaceutical companies for the 37 new specifications<\/li>\n\n\n\n<li><strong>Investment Opportunities<\/strong> | Companies with established generic R&amp;D capabilities positioned to capitalize on newly clarified pathways<\/li>\n\n\n\n<li><strong>Pricing Pressure<\/strong> | Increased generic competition expected for molecules included in the reference list<\/li>\n\n\n\n<li><strong>Export Potential<\/strong> | High-quality generics developed under GQCE standards increasingly competitive in international markets<\/li>\n\n\n\n<li><strong>Regulatory Timeline<\/strong> | Typical generic approval timeline of 2\u20133 years following reference drug designation<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory developments, market opportunities, and competitive dynamics related to China&#8217;s GQCE program. Actual results may differ due to risks including regulatory policy changes, competitive intensity, and market adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Medical Products Administration (NMPA) announced the release of the 105th batch of reference&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[103,14],"class_list":["post-65060","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-gqce-testing","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Medical Products Administration (NMPA) announced the release of the 105th batch of reference drugs for Generic Quality Consistency Evaluation (GQCE) work, comprising 59 specifications in total. The batch includes 37 newly added specifications, with the remaining 22 specifications undergoing modifications to existing reference standards.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=65060\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Medical Products Administration (NMPA) announced the release of the 105th batch of reference drugs for Generic Quality Consistency Evaluation (GQCE) work, comprising 59 specifications in total. The batch includes 37 newly added specifications, with the remaining 22 specifications undergoing modifications to existing reference standards.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=65060\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-12T07:08:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-12T07:08:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65060#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65060\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications\",\"datePublished\":\"2026-05-12T07:08:32+00:00\",\"dateModified\":\"2026-05-12T07:08:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65060\"},\"wordCount\":371,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"GQCE testing\",\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65060#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65060\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=65060\",\"name\":\"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-12T07:08:32+00:00\",\"dateModified\":\"2026-05-12T07:08:33+00:00\",\"description\":\"China's National Medical Products Administration (NMPA) announced the release of the 105th batch of reference drugs for Generic Quality Consistency Evaluation (GQCE) work, comprising 59 specifications in total. The batch includes 37 newly added specifications, with the remaining 22 specifications undergoing modifications to existing reference standards.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65060#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65060\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65060#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Medical Products Administration (NMPA) announced the release of the 105th batch of reference drugs for Generic Quality Consistency Evaluation (GQCE) work, comprising 59 specifications in total. The batch includes 37 newly added specifications, with the remaining 22 specifications undergoing modifications to existing reference standards.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=65060","og_locale":"en_US","og_type":"article","og_title":"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications","og_description":"China's National Medical Products Administration (NMPA) announced the release of the 105th batch of reference drugs for Generic Quality Consistency Evaluation (GQCE) work, comprising 59 specifications in total. The batch includes 37 newly added specifications, with the remaining 22 specifications undergoing modifications to existing reference standards.","og_url":"https:\/\/flcube.com\/?p=65060","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-12T07:08:32+00:00","article_modified_time":"2026-05-12T07:08:33+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=65060#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=65060"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications","datePublished":"2026-05-12T07:08:32+00:00","dateModified":"2026-05-12T07:08:33+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=65060"},"wordCount":371,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["GQCE testing","NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=65060#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=65060","url":"https:\/\/flcube.com\/?p=65060","name":"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-12T07:08:32+00:00","dateModified":"2026-05-12T07:08:33+00:00","description":"China's National Medical Products Administration (NMPA) announced the release of the 105th batch of reference drugs for Generic Quality Consistency Evaluation (GQCE) work, comprising 59 specifications in total. The batch includes 37 newly added specifications, with the remaining 22 specifications undergoing modifications to existing reference standards.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=65060#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=65060"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=65060#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=65060"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65060\/revisions"}],"predecessor-version":[{"id":65061,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65060\/revisions\/65061"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=65060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=65060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=65060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}